PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study to Learn How a Medicine That Reduces Stomach Acid Affects the Level of Sisunatovir in the Blood of Healthy Adults.
- Conditions
- Interventions
- First Posted Date
- 2023-10-30
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 40
- Registration Number
- NCT06105983
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2023-10-30
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 110
- Registration Number
- NCT06106009
- Locations
- 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States
A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants
- Conditions
- Interventions
- First Posted Date
- 2023-10-27
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1280
- Registration Number
- NCT06103734
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
- Conditions
- Interventions
- First Posted Date
- 2023-10-27
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 500
- Registration Number
- NCT06105632
- Locations
- 🇺🇸
Highlands Oncology Group, Springdale, Arkansas, United States
🇨🇦CHU de Québec-Université Laval, Hôpital du Saint-Sacrement, Quebec City, Quebec, Canada
🇨🇳Anhui Provincial Cancer Hospital, Hefei, Anhui, China
A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSV
- Conditions
- Interventions
- First Posted Date
- 2023-10-26
- Last Posted Date
- 2024-10-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 10
- Registration Number
- NCT06102174
- Locations
- 🇨🇳
Hsinchu Municipal Mackay Children's Hospital, Hsinchu City, Hsinchu, Taiwan
🇨🇳Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan
🇺🇸University of Alabama at Birmingham - School of Medicine, Birmingham, Alabama, United States
A Study to Learn About the Study Medicine - Precedex in Children From Japan.
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2024-09-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 110
- Registration Number
- NCT06085573
- Locations
- 🇯🇵
Pfizer, Toykyo, Japan
A Study to Learn About Effects of Living With COVID-19 and the Use of the Medicines Nirmatrelvir-Ritonavir in Treating COVID-19.
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1
- Registration Number
- NCT06085924
- Locations
- 🇨🇳
Pfizer Limited, Taipei, Taiwan
A Study to Learn About Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 15
- Registration Number
- NCT06086353
- Locations
- 🇮🇳
Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, Karnataka, India
Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 779
- Registration Number
- NCT06086340
- Locations
- 🇺🇸
Pfizer New York, New York, New York, United States
A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection
- Conditions
- Interventions
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT06079320
- Locations
- 🇺🇸
Ascension St. John Hospital, Grosse Pointe Woods, Michigan, United States
🇺🇸Oakland Medical Research, Troy, Michigan, United States
🇺🇸Javara - Mankato Clinic, Mankato, Minnesota, United States